TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note Receivable - Related Party - Schedule of Cash Flow in Note Receivable (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Principal	$ 1,432,275us-gaap_NotesReceivableRelatedParties	$ 1,475,766us-gaap_NotesReceivableRelatedParties
Chubeworkx Guernsey Limited [Member]
Principal	1,432,275
Interest	176,296
Total	1,608,571
Chubeworkx Guernsey Limited [Member] \| Next 12 Months [Member]
Principal	291,684
Interest	68,858
Total	360,542
Chubeworkx Guernsey Limited [Member] \| Next 13-24 Months [Member]
Principal	283,606
Interest	49,202
Total	332,808
Chubeworkx Guernsey Limited [Member] \| Next 25-36 Months [Member]
Principal	298,115
Interest	34,693
Total	332,808
Chubeworkx Guernsey Limited [Member] \| Next 37-48 Months [Member]
Principal	313,368
Interest	19,440
Total	332,808
Chubeworkx Guernsey Limited [Member] \| Next 49-60 Months [Member]
Principal	245,503
Interest	4,103
Total	$ 249,606